Access the updated NCCN Guidelines for Patients®: Melanoma. View free resources: https://lnkd.in/dZbFVq2 #CancerAwareness #CancerSupport #CancerResearch #SkinCancer #MelanomaAwareness
National Comprehensive Cancer Network® (NCCN®)’s Post
More Relevant Posts
-
The good news? Melanoma that is diagnosed in its early stages has a high chance of being completely cured. Click here to better understand your risks and to learn the “ABCDE” signs of melanoma to watch for https://bit.ly/3DJr8xE #IMPACTMelanoma #melanomaawareness #MelanomaMonday
To view or add a comment, sign in
-
General Manager Sanofi, LATAM Sr. Marketing Director in Sanofi and Abbott, Sr. Market Access and BD Director Medix
Presented at #ESMO24: Among patients with advanced melanoma, median overall survival was 72 months with nivolumab plus ipilimumab and was 37 months with nivolumab alone, as compared with 20 months with ipilimumab alone. Full CheckMate 067 trial results: nej.md/4dUqm0g
To view or add a comment, sign in
-
This #MAM24, learn more about Shelley Belanger, a mucosal melanoma survivor from Canada who was first diagnosed with mucosal melanoma in 2013. Read Shelley's story here - https://buff.ly/3UJnMl5 #GetNaked #MelanomaAwarenessMonth24
To view or add a comment, sign in
-
What are the actual clinical outcomes when patients receive guideline treatments? In this study, our team examined real-world clinical outcomes for patients with BRAF-mutant advanced/metastatic melanoma. Read the results: https://lnkd.in/g_Y7Dr3W #RWD #RWE #Melanoma
To view or add a comment, sign in
-
#MucosalMelanoma is easier to misdiagnose because of where it is found and the lack of symptoms. That is why it is even more important to notify your doctor if you notice potential signs! During #MelanomAwarenessMonth24, learn more about mucosal melanoma - https://buff.ly/3285nCy #GetNaked #MAM24
To view or add a comment, sign in
-
The phase 1b study provided long-term results form the KEYNOTE-041 trial. A recent analysis of the phase 1b KEYNOTE-041 trial indicated effectiveness and tolerability of pembrolizumab in Japanese patients with advanced melanoma: https://bit.ly/3TSss7T
To view or add a comment, sign in
-
Do you know the ABCDEs of Melanoma? If not, check out the AZ Blue blog: https://lnkd.in/gkZjW9UR #SkinCancerAwarenessMonth
To view or add a comment, sign in
-
Knowledge is power 🧠 Melanoma can be deadly if not detected early and, for many, can come as a surprise diagnosis. Learn everything you need to know about Melanoma in today's blog: https://bit.ly/4dgDDjE #MelanomaMonday #SKINSMART #SKINSMARTacademy#MelanomaAwareness
To view or add a comment, sign in
-
This #MelanomaMonday, let's join forces to raise awareness, support those affected by melanoma, and work towards a future where melanoma is no longer a threat. Together, we can make a difference in the fight against #skincancer. #MelanomaMonday #EarlyDetection #SkinHealth #SkylineDx #skincancer
To view or add a comment, sign in
-
Knowledge is power 🧠 Melanoma can be deadly if not detected early and, for many, can come as a surprise diagnosis. Learn everything you need to know about Melanoma in today's blog: https://bit.ly/4biDxGv #MelanomaMonday #SKINSMART #SKINSMARTacademy#MelanomaAwareness
To view or add a comment, sign in
36,310 followers